Cinepazide

CAS : 23887-46-9

Ref. 3D-FC148892

Informations sur le produit

• Nom: Cinepazide
• Synonymes: 1-(2-oxo-2-pyrrolidin-1-ylethyl)-4-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazine, 1-[4-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one, 1-{4-[2-Oxo-2-(Pyrrolidin-1-Yl)Ethyl]Piperazin-1-Yl}-3-(3,4,5-Trimethoxyphenyl)Prop-2-En-1-One, 2-Propen-1-one, 1-[4-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-, 23887-46-9, Piperazine, 1-[(1-pyrrolidinylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)-, Piperazine, 1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-
• CAS: 23887-46-9

Description

Cinepazide is a drug that is used to treat diabetes mellitus. It is a basic protein that has been shown to have statistically significant effects on neuronal death, mitochondrial membrane potential, and enzyme activities in the mitochondria of rats. Cinepazide also has been shown to have mitochondrial functions. This drug decreases the risk of cardiovascular events in patients with coronary heart diseases and improves energy metabolism by decreasing glucose levels in the blood. Cinepazide may cause side-effects such as headache, dizziness, and nausea.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 417.5 g/mol
• Formule: C₂₂H₃₁N₃O₅
• Degré de pureté: Min. 95%